Doximity (NASDAQ:DOCS) Director Timothy Cabral Sells 20,000 Shares

Key Points

• Doximity Director Timothy Cabral sold 20,000 shares of the company at an average price of $75.00, totaling $1.5 million, significantly reducing his ownership by 86.13%.
• The company's most recent earnings report showed an EPS of $0.36, surpassing analyst expectations, with a 15.2% increase in revenue year-over-year.
• Doximity's stock ratings vary, with a consensus of "Moderate Buy" and a price target around $67.42.

Doximity, Inc. (NASDAQ:DOCS - Get Free Report) Director Timothy Cabral sold 20,000 shares of the business's stock in a transaction dated Wednesday, September 24th. The shares were sold at an average price of $75.00, for a total transaction of $1,500,000.00. Following the transaction, the director directly owned 3,221 shares of the company's stock, valued at $241,575. The trade was a 86.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Doximity Price Performance

DOCS stock traded up $0.08 during midday trading on Friday, reaching $74.46. 1,225,269 shares of the company were exchanged, compared to its average volume of 2,190,604. Doximity, Inc. has a one year low of $40.87 and a one year high of $85.21. The business has a 50-day moving average price of $65.72 and a two-hundred day moving average price of $60.27. The firm has a market capitalization of $13.95 billion, a price-to-earnings ratio of 74.46, a price-to-earnings-growth ratio of 4.10 and a beta of 1.37.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter in the previous year, the business posted $0.28 EPS. Doximity's revenue for the quarter was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. As a group, analysts anticipate that Doximity, Inc. will post 0.99 earnings per share for the current fiscal year.

Institutional Trading of Doximity

Several institutional investors and hedge funds have recently made changes to their positions in DOCS. Texas Permanent School Fund Corp increased its stake in Doximity by 130.7% in the second quarter. Texas Permanent School Fund Corp now owns 145,222 shares of the company's stock valued at $8,908,000 after purchasing an additional 82,274 shares in the last quarter. Osaic Holdings Inc. lifted its holdings in shares of Doximity by 15.2% in the second quarter. Osaic Holdings Inc. now owns 43,426 shares of the company's stock worth $2,661,000 after buying an additional 5,735 shares in the last quarter. B. Riley Wealth Advisors Inc. bought a new position in shares of Doximity in the second quarter worth about $519,000. Marex Group plc bought a new stake in shares of Doximity in the 2nd quarter valued at about $528,000. Finally, Cim LLC grew its stake in shares of Doximity by 4.4% during the 2nd quarter. Cim LLC now owns 59,800 shares of the company's stock worth $3,668,000 after purchasing an additional 2,501 shares during the period. Institutional investors own 87.19% of the company's stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on DOCS shares. Truist Financial raised their price target on shares of Doximity from $52.00 to $61.00 and gave the company a "hold" rating in a report on Thursday, July 17th. Raymond James Financial set a $75.00 price objective on shares of Doximity in a research report on Wednesday, September 10th. Zacks Research lowered shares of Doximity from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. Needham & Company LLC raised their target price on shares of Doximity from $67.00 to $75.00 and gave the stock a "buy" rating in a report on Friday, August 8th. Finally, KeyCorp increased their target price on shares of Doximity from $65.00 to $70.00 and gave the stock an "overweight" rating in a report on Monday, July 14th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and eleven have assigned a Hold rating to the company. Based on data from MarketBeat.com, Doximity presently has a consensus rating of "Moderate Buy" and a consensus price target of $67.42.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.